Overview

Update
Status
Biosyntech has been closed
Total Equity Funding
$1.4M in 1 Round from 4 Investors
Headquarters:
Laval, QC
Description:
Biosyntech is engaged in the development of biotherapeutic thermogels for tissue repair and the delivery of therapeutic agents.
Categories:
Biotechnology
Website:
http://www.biosyntech.com

Company Details

Update

BioSyntech, Inc. develops biotherapeutic thermogels designed for tissue repair and delivery of therapeutic agents. Its technology platform is BST-Gel, a family of hydrogels based on chitosan, a natural biopolymer derived from crustacean shells. The company’s lead products in clinical trials include BSTCarGel for cartilage repair; BST-DermOn for wound healing; and BST-InPod for the treatment of chronic pain due to plantar fat pad atrophy in the heel and forefoot.

Biosyntech has a collaboration with Nicholas Piramal India, Ltd. to involve in the clinical studies for BST-InPod, which is being developed to alleviate the chronic pain associated with foot fat pads. The company was incorporated in 1994 and is headquartered in Laval, Canada.

Funding Rounds (1) - $1.4M

Update
DateAmount / RoundValuationLead InvestorInvestors
Aug, 2009$1.4M / Venture4

News (1)

Update
DateNews
Sep 29, 2009biosyntech.com - Biosyntech raises 1400000 in unknown round

Offices/Locations (1)

Update
  • HQ

    475 Armand-Frappier Blvd.

    Laval, QC H7V 4B3

    CAN

Images (1)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos